Idexx Laboratories Inc
IDXX
Key stats
- Open
- 711.68
- Day high
- 712.88
- Day low
- 696.72
- Previous close
- 702.59
- Volume
- 487.6K
- VWAP
- 701.19
- 52-week high
- 769.98
- 52-week low
- 500.61
- Market cap
- 55.35B
- Shares out
- 78.79M
- Employees
- 11,000
- Listed
- 1991
About Idexx Laboratories Inc
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · WESTBROOK, ME · idexx.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 447
- Put open interest
- 133
- Put/call
- 0.30
- At-the-money IV
- 32.3%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 750 call | 1.20 | Nov 10, 10:56 AM | 10 | 11 | 40.6% |
| 630 put | 1.00 | Nov 11, 9:30 AM | 10 | 18 | 54.4% |
| 800 put | 90.51 | Nov 4, 2:13 PM | 10 | 0 | — |
| 590 call | 83.56 | Nov 2, 3:30 PM | 7 | 7 | 55.0% |
| 620 call | 54.52 | Nov 2, 1:20 PM | 6 | 6 | 41.4% |
| 580 put | 2.47 | Nov 6, 11:47 AM | 6 | 8 | 70.1% |
Quarterly results
Massive · Nov 2, 2026| Q3 2026 to Sep 30, 2026 | Q2 2026 to Jun 30, 2026 | Q1 2026 to Mar 31, 2026 | Q4 2025 to Dec 31, 2025 | |
|---|---|---|---|---|
| Revenue | $1.21B | $1.22B | $1.14B | $1.09B |
| Gross profit | $764.30M | $779.09M | $722.74M | $658.11M |
| Operating income | $402.35M | $425.57M | $362.59M | $315.61M |
| Net income | $317.14M | $338.41M | $278.45M | $248.19M |
| Diluted EPS | 4.01 | 4.27 | 3.47 | 3.08 |
| Operating cash flow | $453.83M | $347.16M | $266.25M | $355.76M |
| Assets | $3.71B | $3.44B | $3.39B | $3.35B |
| Liabilities | $1.84B | $1.83B | $1.83B | $1.75B |
| Equity | $1.87B | $1.61B | $1.56B | $1.61B |
Technicals
Massive · Nov 12, 2026- 50-day average558.91
- 200-day average572.21
- RSI (14 days)70.5
Short interest
Massive · Oct 30, 2026- Oct 30, 20262.35M shares · 4.5 days to cover
- Oct 15, 20261.93M shares · 3.6 days to cover
- Sep 30, 20261.94M shares · 3.9 days to cover
- Sep 15, 20261.92M shares · 3.8 days to cover
Splits
Massive · Jun 16, 2015- Jun 16, 20152-for-1
- Nov 27, 20072-for-1
Related companies
MassiveNews coverage
No stories about Idexx Laboratories Inc right now.